Miss Ruth Bosire, NP | |
15800 Dooley Rd, Suite 185, Addison, TX 75001-4284 | |
(972) 661-2273 | |
(866) 292-6489 |
Full Name | Miss Ruth Bosire |
---|---|
Gender | Female |
Speciality | Clinical Nurse Specialist - Acute Care |
Location | 15800 Dooley Rd, Addison, Texas |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1336564103 | NPI | - | NPPES |
680964 | Other | TX | TNB LICENSE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
364SA2100X | Clinical Nurse Specialist - Acute Care | AP124766 (Texas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Miss Ruth Bosire, NP 15800 Dooley Rd, Suite 185, Addison, TX 75001-4284 Ph: (972) 661-2273 | Miss Ruth Bosire, NP 15800 Dooley Rd, Suite 185, Addison, TX 75001-4284 Ph: (972) 661-2273 |
News Archive
COPAN announced this week that it has received the Japanese patent for the invention of flocked swabs, FLOQSwabs, for collection and transfer of biological samples. The Japanese flocked swabs patent (2007-523663) is the latest addition to a growing number of patents held by COPAN across the world for the use of flocked swabs for collection and transfer of biological samples, including the Australian patent (2004226798) granted earlier this year, a European patent that covers several countries (1608268), a Canadian patent (2515205), and New Zealand patent (541560).
A variety of medications can help reduce the core symptoms of post-traumatic stress disorder (PTSD) as well as reduce associated depression and disability, but selective serotonin reuptake inhibitors (SSRIs) should be considered as first line agents as there is most evidence showing that these can be effective.
Pfizer Inc. and Zhejiang Hisun Pharmaceutical, a leading pharmaceutical company in China, today signed a framework agreement, advancing their previously announced memorandum of understanding (MOU) to establish a joint venture to develop, manufacture and commercialize off-patent pharmaceutical products in China and global markets.
Marblar is gamifying the process of technology transfer. We post technology on our platform in the form of a challenge, and the Marblar community then competes to uncover new problems these technologies could solve – thereby discovering new market applications for these technologies.
› Verified 7 days ago